Cannabis and Pain.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Nanotechnology for the Efficacious Delivery of Medicinal Cannabis and Pharmaceutical Medicines.Pharmaceuticals (Basel, Switzerland) · 2025
   Review
2. Recreational Cannabis Laws and Fills of Pain Prescriptions in the Privately Insured.Cannabis (Albuquerque, N.M.) · 2025
   Article
3. Dispensing Medical Advice: San Francisco Bay Area Budtender Recommendations for Pain and Sleep Relief.Cannabis (Albuquerque, N.M.) · 2025
   Article
4. Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions.Inflammopharmacology · 2022
   Review
5. A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products.Cannabis and cannabinoid research · 2022
   Article
6. Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain.PloS one · 2022
   Article
7. Enhancing Endocannabinoid Control of Stress with Cannabidiol.Journal of clinical medicine · 2021
   Review
8. Consensus-based recommendations for titrating cannabinoids and tapering opioids for chronic pain control.International journal of clinical practice · 2021
   Article
9. Safety Considerations in Cannabinoid-Based Medicine.International journal of general medicine · 2020
   Review

Corrections and comments

• Commented on by
  When The Pharmacopoeia Fails: Cannabis for Pain.2023
• Comment on
  Cannabis for the Treatment of Chronic Pain in the Era of an Opioid Epidemic: A Symposium-Based Review of Sociomedical Science.2019
• Comment on
  Restored Self: A Phenomenological Study of Pain Relief by Cannabis.2019

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as